LEONARD FRANK X (Chief Development Officer) sold 1.1% of their position (5.61K shares) of NOVOCURE LTD on the open market
Open‑market sale worth $74.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2026ACC: 0001822879-26-000003
Officer· Chief Development Officer
Since Sep 2020
+360.78K
Net shares
Net buyer
$74.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
366.39K acquired · 5.61K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
42.9%
3/3/2026
349.40K→499.40K
Ordinary Shares
Direct
Shares
−5.61K
Price / share
$13.31
Trade value
$74.60K
% of position
1.1%
3/4/2026
499.40K→493.79K
Total
Net shares
+144.39K
Net value
-$74.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/3/2026 | A · Award | +150K | — | — | 42.9% | 349.40K | 499.40K |
| Ordinary Shares Direct | 3/4/2026 | S · Sale | −5.61K | $13.31 | $74.60K | 1.1% | 499.40K | 493.79K |
| Total | +144.39K | -$74.60K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
216.39K shares
Shares
+216.39K
Strike price
13.30
Held after
216.39K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares216.39K shares | 3/3/2026 | A · Award | +216.39K | 13.30 | — | 216.39K |